← Evidence map

ArticleEXCLI journal2012

Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease.

Babak Saffari et al.PubMed ↗Full text ↗

No numbers read from the abstract.

1 paper cites it

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this papercites it

Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease. | OpenQuestion